Hematologist, Myeloma Expert, Communication Enthusiast. Professor at TGen/City of Hope and Director of Myeloma Research at the HonorHealth Research Institute
Arizona, USA
Joined March 2014
- Tweets2.8K
- Following482
- Followers7.8K
- Likes7.5K
Pinned Tweet
Missed yesterday's #NDMM video...archived 👇
or on YouTube👉youtu.be/-QGQEm-vIYc
🏆Claim CME bonumce.com/ndmmvideo
Want to skip ahead👇
3:20⚖️Factors influencing tx selection
8:45🔺PERSEUS
11:15🔺GMMG-HD7
15:55🔺IMROZ
17:15🔺CEPHEUS
21:00📟Role of MRD in Clin Practice
#NDMM Quad Tx Efficacy 🎥 Discussion w/ @DrKrinaPatel & @JMikhaelMD #MMSM xitter.gq/i/broadcasts/1MYxNlARX…
Joseph Mikhael retweeted
Houston! Hip-hop meets health equity at a free event this Saturday, 11/7. Come for live conversations with patients, care partners, & myeloma experts, plus a live DJ, food, vendors, and connections with the community. Register at healthhopehiphop.org/mic-che…
@HHHHFoundation
Joseph Mikhael retweeted
An effective Board of Directors can shape an organization. @montypal has the vision and leadership to guide and grow ASCO nationally and internationally.
Voting for the ASCO Election is now open. I am honored to be running as one of the candidates for the ASCO Board. Visit asco.org/election to learn more about the candidates and place your vote!
Please consider supporting Monty as he is an outstanding candidate for this role!
Voting for the ASCO Election is now open. I am honored to be running as one of the candidates for the ASCO Board. Visit asco.org/election to learn more about the candidates and place your vote!
Joseph Mikhael retweeted
Join us for the upcoming IACH Multiple Myeloma Masterclass Series:
Making sense of treatment options at first relapse
with Joseph Mikhael
Thursday, November 12
6 pm CET • 12 pm NY
Register now for free👇
us06web.zoom.us/webinar/regi…
@jmikhaelmd @Mohty_EBMT
Joseph Mikhael retweeted
Can You Take GLP-1s With Multiple Myeloma? CAR T, Revlimid & Treatment
Are GLP-1 medications safe for people with multiple myeloma? Can patients stop Revlimid maintenance after two years? And who may be eligible for CAR T-cell therapy? myeloma.org/node/13086
Joseph Mikhael retweeted
How might iberdomide help address treatment challenges in lenalidomide-refractory multiple myeloma?
In this episode of Training Academy, join @jmikhaelmd, Dr. Paul Richardson of @DanaFarber, and Dr. Scott Goldsmith of @cityofhope as they break down the latest data and explore what it could mean for treatment.
▶️ Watch the expert discussion: hubs.li/Q04B7PJ_0
#CancerNetwork #MultipleMyeloma #Oncology
Joseph Mikhael retweeted
This will be a great discussion. I’m looking forward to attending. @IMFMyeloma @Bethfaiman @JoshuaRichterMD @JMikhaelMD.sm #myeloma
When experts disagree, it can be hard to know what's right for you. Learn why opinions differ and how to talk through your options with your care team. Free virtual workshop Nov 16 at 3 PM PT / 6 PM ET.
myeloma.org/videos/vcw-whats…
Joseph Mikhael retweeted
I will be speaking at the IMF's free online Myeloma Community Workshop: "What's the Right Answer? - Controversies in Myeloma." When experts disagree, it can be hard to know what's right for you. Register now at myeloma.org/videos/vcw-whats… #mmsm #multiplemyeloma @IMFmyeloma
Joseph Mikhael retweeted
Breakthroughs are no accident. Myeloma research relies on the myeloma community and their participation in clinical trials. Find a clinical trial near you at myeloma.org/sparkcures #AsktheIMF
@jmikhaelmd
Joseph Mikhael retweeted
What is this new class of drugs in multiple myeloma? IMF Medical Advisor @jmikhaelmd explains what CELMoDs are and how they work.
#AsktheIMF
Joseph Mikhael retweeted
Myeloma patients see a lot of blood tests. Which ones are worth paying attention to?
@jmikhaelmd
#AsktheIMF
Joseph Mikhael retweeted
If MGUS can become multiple myeloma, why don't doctors treat it? IMF Medical Advisor @jmikhaelmd explains why MGUS is typically not treated and why routine monitoring is important.
#AsktheIMF
Joseph Mikhael retweeted
That is one of the best analogies Joe…!!! Dont be surprised if someone explains it back to the founder..🙂 (we are going to publicize this)
Joseph Mikhael retweeted
If your myeloma is in remission, does that mean you're cured? IMF Medical Advisor @jmikhaelmd explains what remission means in multiple myeloma and why remission and cure are not the same thing.
myeloma.org/videos/does-remi…
Joseph Mikhael retweeted
A fantastic start to the day at #IMS26. 🏴
We've already had some great discussions with experts, including @SagarLonialMD, @jmikhaelmd, & @IrenemGhobrial.
To hear insights into updated data on iberdomide for R/R #MultipleMyeloma, access to BCMA-targeted therapy, and macrophage reprogramming in smoldering #Myeloma, keep an eye on VJHemOnc.com!
#MMsm @Myeloma_Society
Joseph Mikhael retweeted
Why go through autologous stem cell transplant when newer treatments for myeloma exist? Find out in this short video from myeloma expert @jmikhaelmd.
#asktheIMF #knowmyeloma
Joseph Mikhael retweeted
Miembros de GELAMM y GBRAM participaron en una importante reunión del LAMN, un espacio de encuentro y colaboración para compartir experiencias y generar nuevas iniciativas.
💙 Seguimos trabajando para cambiar el presente y construir el futuro del mieloma múltiple en Latinoamérica – at Buenos Aires, Argentina
Joseph Mikhael retweeted
Dr. Joseph Mikhael has a personal invitation for hematology and oncology fellows.
Join him at #LLMCongress to learn from leading experts, then connect with faculty and peers at the dedicated Fellows Reception.
bit.ly/4wApXsY
Joseph Mikhael retweeted
How has myeloma survival changed over the past few decades? IMF Medical Advisor @jmikhaelmd recounts the differences in myeloma, then and now.
#asktheIMF #knowmyeloma